MPs are urging Keir Starmer to scrap a controversial healthcare agreement dubbed the “Trump tax” and redirect funds towards fixing the UK’s struggling social care system. The Liberal Democrats have criticized the Prime Minister for allegedly bowing to pressure from the US President in striking a new trade deal. While experts predict a significant increase in pharmaceutical costs due to the agreement, the government disputes these estimates.
The trade deal involves raising price limits on medicines by up to 25%, although the government touts it as a milestone achievement, highlighting the zero percent tariff secured on pharmaceuticals exported to the US. Amid mounting pressure on the PM to expedite social care reforms, data reveals that over 4.3 million days were spent by patients in hospital who could have been discharged if proper care facilities were in place by 2024/25.
Daisy Cooper, the Deputy Leader of the Liberal Democrats, criticized Starmer for prioritizing payments to the White House over addressing social care funding shortages. She called for immediate action to tackle the crisis and fulfill promises to reform the social care system. Despite a commission being set up for social care overhaul post the 2024 general election, final recommendations are not expected until 2028.
The UK-US agreement has faced criticism for potentially inflating drug costs by £3 billion yearly, according to The Lancet journal. However, the government refutes these claims, emphasizing the deal’s benefits in safeguarding drug supplies and securing advantageous terms for UK medical technology exports. Officials maintain that the deal is a crucial investment that builds on the NHS’s strengths and enhances access to life-saving medications.
In response to concerns, a government spokesperson clarified that no frontline NHS services would suffer cuts to finance the trade deal. Efforts are underway to address delays in hospital discharges and enhance NHS productivity through increased investments and collaboration with social care authorities. The government aims to streamline hospital discharge processes, provide comprehensive guidance, and integrate healthcare and social care services for improved patient outcomes.
Robert F. Kennedy, Jr., a prominent figure in US healthcare, praised the UK-US agreement for promoting innovation in pharmaceuticals and balancing trade relations. He commended President Trump for his leadership in driving reforms that prioritize American interests.